Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fritsche

Showing results (31-40 of 214) with videos related to

Pageof 22
Sort By:
Diagnostic Microbiology and Infectious Disease|March 21, 2008
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United StatesDouglas J Biedenbach, Ronald N Jones, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)Ronald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)Ronald N Jones, Helio S Sader, Thomas R Fritsche
International Journal of Antimicrobial Agents|March 12, 2004
Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptideRonald N Jones, Jennifer M Streit, Thomas R Fritsche
American Journal of Clinical Pathology|May 1, 1992
Dirofilaria repens manifesting as a breast nodule. Diagnostic problems and epidemiologic considerationsL T MacDougall, C C Magoon, T R Fritsche
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 10, 2004
Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylaseT R Fritsche, G J Moet, R N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 22, 2008
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patientsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|March 18, 2009
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolatesHelio S Sader, Thomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|December 31, 2008
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrheaThomas R Fritsche, Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|October 3, 2003
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002)Thomas R Fritsche, Helio S Sader, Ronald N Jones
Pageof 22

Showing results (31-40 of 214) with videos related to

Sort By:
Pageof 22
Diagnostic Microbiology and Infectious Disease|March 21, 2008
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United StatesDouglas J Biedenbach, Ronald N Jones, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)Ronald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|June 9, 2004
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)Ronald N Jones, Helio S Sader, Thomas R Fritsche
International Journal of Antimicrobial Agents|March 12, 2004
Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptideRonald N Jones, Jennifer M Streit, Thomas R Fritsche
American Journal of Clinical Pathology|May 1, 1992
Dirofilaria repens manifesting as a breast nodule. Diagnostic problems and epidemiologic considerationsL T MacDougall, C C Magoon, T R Fritsche
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 10, 2004
Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylaseT R Fritsche, G J Moet, R N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 22, 2008
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patientsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|March 18, 2009
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolatesHelio S Sader, Thomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|December 31, 2008
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrheaThomas R Fritsche, Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|October 3, 2003
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002)Thomas R Fritsche, Helio S Sader, Ronald N Jones
Pageof 22